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Many environmental pollutants have estrogenic activity in animals. Xenobiotic estrogens include many pesticides and industrial chemicals that bioac-
cumulate. The impact of these common pollutants on the reproductive success of wildlife may be considerable, particularly in threatened or endan-
gered species. This research examined the use of plasma vitellogenin in males as a biomarker for estrogenic xenobiotics in reptiles and amphibians.
Adult male turtles (Trachemys scripta) and frogs (Xenopus laevis) were given ip injections of estradiol-17f (E2), diethylstilbestrol (DES), or o,p'DDT
(1-chloro-2-[2,2,2-trichloro-1-(4-chlorophenyl)ethyllbenzene) daily for 7 days, and plasma was collected on day 14. The estrogenic activity of each
compound was determined by measuring the induction of plasma vitellogenin. Vitellogenin was identified by precipitation, electrophoresis, Western
blot, and enzyme-linked immunosorbant assay (ELISA). In both species, estradiol and DES treatments induced the most vitellogenin, whereas DDT
treatments induced smaller amounts of vitellogenin in a dose-dependent fashion. These data indicate that induction of plasma vitellogenin in males
may be a useful biomarker of xenobiotic estrogen activity in wild populations of reptiles and amphibians. - Environ Health Perspect 103
(Suppl 4):19-25 (1995)
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Introduction
Xenobiotic estrogens in the environment
pose an insidious risk to both wildlife and
humans. By disrupting reproduction and
developmental processes, they may impair
not only the individuals exposed, but have
lasting influence on their offspring as well.
Xenobiotic estrogens include many herbi-
cides, fungicides, insecticides, and industri-
al chemicals. At least 45 chemicals or their
metabolites have been identified as
endocrine disrupters (1). The impact of
these common pollutants on the reproduc-
tive success ofwildlife may be considerable.
Due to their lipophilic nature and persis-
tence in the environment, many of these
compounds bioaccumulate (2). Therefore,
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those most affected will be those in the
upper food chain or aquatic species that are
exposed to high doses due to toxic accumu-
lation in aquatic ecosystems.
A rapid, sensitive, and inexpensive test
to screen wildlife for the effects ofestrogenic
chemicals is greatly needed. This test should
be one that demonstrates not merely the
presence of a compound in the tissues or
body fluids, but measures a biological effect.
An ideal test should meet several criteria,
specifically a) have widespread applicability
across many animal groups; b) require a
small and easily obtainable sample without
causing undue harm or distress to the ani-
mals; c) measure a physiological response to
xenobiotic compounds; d) measure a
response through known biochemical path-
ways; e) be responsive to a large class of
estrogenic chemicals; andf) be quantifiable.
One of the most important and sensi-
tive responses to estrogen is the induction
of protein transcription and translation
(3,4). Particularly well known among these
responses is estrogenic induction of the
lipoprotein vitellogenin, expressed in all
oviparous and ovoviviparous vertebrates
(5,6). This makes testing for vitellogenin
useful as an indicator of estrogenic activity
over a wide range of vertebrate groups.
Further, the mechanism has been studied in
detail as a model ofestrogen action (4-13).
Vitellogenin is produced bycells in the liver
in response to estrogen. The response is
only elicited if an estrogenic compound
binds to and activates estrogen receptors in
hepatocytes. In females, vitellogenin is
transported in the circulatory system to the
ovaries, where it is incorporated into the
developing ovarian follicles as yolk.
Males normally have no detectable pro-
duction of vitellogenin due to their nor-
mally low levels of endogenous estrogens
(13-18). However, their liver is capable of
synthesizing and secreting vitellogenin into
the blood in response to exogenous estro-
gen stimulation (6,17-25). The response is
not as rapid or as strong as in females that
are exposed to the same concentrations of
estrogen (18). However, since males nor-
mally have no vitellogenin, the expression
of any vitellogenin serves as an ideal bio-
marker for xenobiotic estrogenic stimula-
tion. Vitellogenin expression has been used
successfully for identification of exposure
to environmental estrogens in fish, includ-
ing wild populations (26,27), and under
laboratory (28) and in vitro conditions
(29,30).
This study was undertaken to deter-
mine ifplasma vitellogenin is inducible by
xenobiotic estrogens in male turtles and
frogs, therefore making it a potential bio-
marker of xenobiotic estrogen exposure in
reptiles and amphibians. Turtles and frogs
were exposed to a) natural estrogen, estra-
diol-17, (E2); b) a well-known artificial
estrogen, diethylstilbestrol (DES); and c)
an important environmental estrogen, the
pesticide o,p'-DDT. Measurable vitel-
logenin was induced in both turtles and
frogs, indicating that vitellogenin may be
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useful as a biomarker for xenobiotic estro-
gen exposure in amphibians and reptiles.
Materials and Methods
Speies
Adult red-eared turtles (Trachemys scripta)
were purchased from a commercial dealer
(Lemberger; Oshkosh, WI). The turtles
were housed in large Rubbermaid tubs
(1.25 m longx0.75 m widex0.75 m deep)
at 21°C. Each tub was supplied with a
basking ramp mounted 0.3 m below 150-
watt flood lamps. This allowed the animals
to thermoregulate their body temperature.
Food (Wardley Pond-Ten; Secaucus, NJ)
was provided adlibitum 3 days perweek.
Adult male African clawed frogs
(Xenopus laevis) were purchased from a
commercial dealer (Sullivan; Nashville,
TN). The frogs were divided randomly into
groups of5 and housed in 5-gal glass aquar-
ia in 10 cm of water maintained at room
temperature (21QC). Food (Wardley Pond-
Ten) was provided 3 days perweek, and the
water was changed the following day.
Chemicals
Estradiol-170 (E2; Sigma, St. Louis, MO),
diethylstilbestrol (DES; Sigma), and o,p'-
DDT (1-chloro-2-[2,2,2-trichloro-1-(4-
chlorophenyl)ethyl] benzene;
AccuStandard, New Haven, CT) were dis-
solved in corn oil. Placebos consisted of
pure corn oil. Volumes of all injections
were equilibrated across treatment groups
for each species.
Production ofTurdeVitellogenin for
AntibodyProduction
Six adult female turtles were injected daily
with 1 pg/g E2 for 7 days, and on alternate
days until day 21. Blood was collected from
the caudal vein ofeach turtle using a 1-ml
syringe and a 26-gauge needle (31). Whole
blood was centrifuged in heparinized tubes
for 2 min at 14,000g, and the plasma was
separated and frozen at -20°C. Vitellogenin
was purified by precipitation and checked
for purity byelectrophoresis.
PurificationofViteilogenin
The protocol for purification of vitel-
logenin was modified from that described
by Wiley (32). Two-hundred fifty micro-
liters of plasma sample were gently mixed
with 1 ml of20 mM Na2EDTA and 80 pl
of0.5-M MgCl2 and centrifuged at 2500g
for 15 min. The supernatant was discard-
ed, and the pellet containing vitellogenin
was redissolved in 150 pl of 1 M NaCl, 50
mM Tris-HCl (pH 7.5) and then cen-
trifuged at 2500g for 30 min. The super-
natant was removed to another centrifuge
tube, and then vitellogenin was precipitat-
ed with 1.24 ml distilled H20 and cen-
trifuged at 2500gfor 15 min. The resulting
pellet of purified vitellogenin was redis-
solved in IM NaCl, 50 mM Tris-HCI (pH
7.5) and stored at -20°C. Purification of
frog vitellogenin was performed using 50
pl of plasma and proportionately reduced
quantities ofother reagents. Quantification
of vitellogenin was accomplished using
Lowry reagent (BioRad, Melville, NY).
PolyclonalAntibodyProduction and
Purification
Turtle (T scripta) vitellogenin was purified
as above and used to produce polyclonal
antibodies in rabbits. Turtle vitellogenin
(0.50 mg in 1 ml of 1 M NaCl, 50 mM
Tris-HCl, pH 7.5) was mixed with 1 ml of
Freund's complete adjuvant and injected
intradermally at four to six sites along the
back of rabbits using a 20-gauge 1.5-inch
needle. Using the above protocol the
rabbits were boosted twice with Freund's
incomplete adjuvant at 3-week intervals.
The rabbits were bled by cardiac puncture
under deep anesthesia. The blood was
allowed to clot at 40C overnight to separate
the serum, which was then stored at
-800C.
Antivitellogenin antibodies were puri-
fied using a procedure modified from
Harlow and Lane (33). A 1-ml column was
prepared by swelling 0.3 g Sepharose-4B-
CNBr in 1 mM HCl for 15 min, rinsing
with 70 ml of 1 mM HCl, and washing 3
times with 1 ml coupling buffer (0.5 M
NaPO4, pH 7.5). Precipitation-purified
vitellogenin was dissolved in coupling
buffer (20 mg/2 ml), added to the
Sepharose column, agitated overnight, and
rinsed twice with coupling buffer. The
column was washed once with 1 M NaCl,
0.05 M NaPO4 (pH 7.5) and incubated
overnight, with gentle rocking, at room
temperature with 10 vol ofblocking buffer
(100 mM ethanolamine, pH 7.5). The
column was washed twice with phosphate-
buffered saline (PBS; 140 mM NaCl, 3
mM KCl, 10 mM Na2HPO4, 2 mM
KH2PO4) and merthiolate added to 0.01%
and stored at 40C until use.
Before use, the column was rinsed with
10 ml of 10 mM Tris buffer (pH 7.5) and
flushed with 10 ml of 100 mM glycine
buffer, pH 2.5, followed by 10 ml of 10
mM Tris buffer pH 8.8. The column was
then washed with 10 ml of 100 mM
triethylamine (pH 11.5), followed by 10
ml of 10 mM Tris, pH 7.5.
Following column preparation, poly-
clonal antiserum specific to vitellogenin
was diluted to 10% in 10 mM Tris, pH
7.5 and passed through the column 3 times
with a flow rate of 1 ml/min. The column
was washed with 20 ml of 10 mM Tris,
pH 7.5 and then 20 ml of500 mM NaCl,
10 mM Tris-buffered saline (pH 7.5). The
column was eluted with 20 ml of 100 mM
glycine buffer, pH 2.5, and the antibodies
collected in a tube containing 1 ml of 1 M
Tris, pH 8.8. The column was washed
with 10 mM Tris, pH 8.8, the column
eluted again with 10 ml of 100 mM tri-
ethylamine, pH 11.5. Antibodies were col-
lected in a tube containing 1 ml of 1 M
Tris, pH 8.8. The vitellogenin antibody
fractions were combined and dialyzed
against PBS with 0.02% sodium azide.
Specificity of purified antivitellogenin
antibody was tested against whole plasma,
precipitation-purified vitellogenin, a protein
of 214 kDa (the presumptive vitellogenin
identified electrophoretically) electroeluted
from 5% PAGE, and bovine serum albumin
(BSA). Antivitellogenin antibodies were
tested by enzyme-linked immunosorbant
assay (ELISA) and Western blot to deter-
mine cross-reactivity. Controls included
omission of protein antigen, omission of
primary antibody, and omission of sec-
ondary antibody. Only batches of purified
antivitellogenin antibody that exhibited
high affinity for vitellogenin and minimal
cross-reactivity with other antigens were
used in immunodetection.
One-dimensional Polyacrylamide Gel
Electophoresis
Whole plasma or purified vitellogenin
amples were solubilized in 10 mM Tris
buffer (pH 7.4) containing 2% (w/v)
sodium dodecyl sulfate (SDS) and 10%
(v/v) 2-mercaptoethanol and separated by
molecular weight using one-dimensional
SDS polyacrylamide gel electrophoresis
(1D-SDS-PAGE). Separation gels were
made from 5% T (total acrylamide) to
facilitate analyses ofhigh molecular weight
proteins (34). Plasma samples or purified
vitellogenin were loaded on to a discontin-
uous PAGE apparatus, then run at 200 V
for 35 min or until complete. The gels
were fixed and stained with Coomassie
blue (34) and silver (35). Molecular
weights were determined using BioRad
high molecular weight standards and calcu-
lation of Rf values (36). Vitellogenin was
quantified from 1D-SDS-PAGE ofplasma
using a BioRad GS-670 imaging densito-
meter to digitize the images. The concen-
trations of vitellogenin (band densities)
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were calculated by plotting the band
absorbance and integrating the area under
the curve for vitellogenin (BioRad
Molecular Analyst software). Comparisons
of treatment groups were performed using
Kruskal-Wallis one-way analysis of
variance on ranks (ANOVA: p< 0.05).
Multiple means comparisons were per-
formed using the Student-Newman-Keuls
method (37).
Westem Blotting
To identify vitellogenin immunologically,
whole plasma proteins or precipitation
purified vitellogenin were transferred to
polyvinylidene difluoride (PVDF) mem-
branes immediately following 1D-SDS-
PAGE. Briefly, the gels were equilibrated
in transfer buffer (25 mM Tris, 192 mM
glycine, 20% v/v methanol) (38) immedi-
ately following electrophoresis, and the
proteins were transferred to a PVDF mem-
brane under a 15V electrical field for 1 hr.
After transfer, the PVDF membrane was
equilibrated in Tris-buffered saline (TBS;
25 mM Tris, 0.3M NaCl, pH 7.4) for 15
min, blocked with 5% (w/v) powdered
milk in TBS (2 hr), and incubated
overnight with primary antibodies (diluted
1:50,000 in 5% (w/v) powdered milk in
TBS) specific for vitellogenin. The transfer
membrane was washed in TBS (3x5 min)
and incubated for 2 hrwith goat anti-rabbit
immunoglobulin conjugated to alkaline
phosphatase (Sigma) diluted 1:1,000 in
5% powdered milk in TBS. The PVDF
membrane was washed again in TBS (3x5
min), and incubated at 37°C in 0.1 g/l
nitro blue tetrazolium (NBT), 0.05 g/l 5-
bromo-4-chloro-3-indolyl phosphate
(BCIP) and 2 mM MgCl2 in 0.1M Tris
buffer (pH 8.8 for 15 min) for localization
ofreactive proteins.
InductionofVitellogenin inTurtles
withE2, DES, and o,p'-DDT
Adult male turtles were ranked by mass
and divided into experimental and control
groups to equalize specimen sizes among
treatments. The treatment groups consist-
ed of animals treated with 1 pg/g E2, 1
pg/g DES, 250 pg/g o,p'-DDT, 1 pg/g
o,p'-DDT, and oil only as control. Each
compound was dissolved in 0.1 ml corn oil
and injected ip. The treatments were given
daily for 7 days. Plasma was collected on
day 14 from the caudal vein ofeach turtle
using a 1-ml syringe and a 26-gauge needle
(31). Whole blood was spun in
heparinized tubes for 2 min at 14,000g,
and plasma was separated and frozen at
-20°C. This treatment protocol with
exogenous E2 has been shown to produce
circulating concentrations of serum E2 in
turtles ofapproximately 333 pg/ml (Selcer
and Palmer, unpublished data), which is
equivalent to E2 concentrations in females
during natural vitellogenesis.
Induction ofVitellogenininFrogs
withE2, DES, and oj,-DDT
Twenty-five adult male frogs of matched
size were randomly assigned into treatment
groups offive and housed in separate 5 gal
aquaria with 10 cm of water. The treat-
ment groups consisted of animals treated
with 1 pg/g E2, 1 pg/g DES, 250 pg/g
o,p'-DDT, 1 pg/g o,p'-DDT, and oil only
as control. Compounds were dissolved in
40 pl ofcorn oil and injected ip. Injections
were given daily for 7 days, and frogs were
bled by cardiac puncture on day 14. Whole
blood was centrifuged in heparinized tubes
for 2 min at 14,000g, and plasma separated
and frozen at-20°C.
ELISA
ELISA (enzyme-linked immunosorbant
assay) was used to determine relative levels
of vitellogenin in plasma samples. Ten-
microliter plasma samples and 10 Ill excess
BSA were each diluted with 40 pl TBS (25
mM Tris, 0.3M NaCl, pH 7.4). The dilut-
ed plasma solutions were added to individ-
ual wells of a polystyrene microtiter plate,
and the BSA solution was added to a single
well as a control; and the plate was incu-
bated overnight at 40C. Plates were washed
three times with TBS-Tween (TBS plus
0.2% Tween 20) and blocked with 150 pl
Blotto-Tween (5% nonfat dry milk, 0.2%
Tween 20, and 0.02% sodium azide in
TBS) for 2 hr. The plates were washed
three times with TBS-Tween, and 50 pl
antivitellogenin antibodies diluted
1:20,000 in Blotto-Tween were added to
each well. The plates were then incubated
for 2 hr at room temperature. The plates
were thoroughly washed four times with
Blotto-Tween and incubated for 2 hr with
goat anti-rabbit immunoglobulin conjugat-
ed to alkaline phosphatase (Sigma) diluted
1:1,000 in Blotto-Tween. After thoroughly
washing each well with TBS-Tween 4
times, the plates were developed in 0.1%
(w/v) p-nitrophenyl phosphate (PNPP) in
developing buffer (0.1 M NaCI, 0.1 M
Tris, 5 mM MgCl2, pH 9.5) and incubat-
ed for 15 min at room temp. The reaction
was stopped with 50 1l of stop buffer (20
mM Tris, 5 mM EDTA, pH 7.5), and the
plate densities were read on a Bio Tek
Microplate Reader at 405 nm. The well
coated with BSA served as the reagent
blank, and its absorbance was subtracted
from that of the other wells. Statistical
comparisons among treatment groups were
performed using Kruskal-Wallis one-way
analysis of variance on ranks (ANOVA:
p<0.05) Multiple means comparisons were
performed using the Student-Newman-
Keuls method (37).
Results
InductionofMitellogenin inTurtles
A protein of 214 kDa was extractable
from E2, DES, and both o,p'-DDT treat-
ment groups. This protein exhibited
cross-reactivity with antivitellogenin anti-
bodies in Western blots (Figure 1) and
was identified as vitellogenin. ELISA
analyses ofday 14 turtle plasma indicated
significant (p<0.001) induction of vitel-
logenin production from E2, DES, and
both DDT treatments (Figure 2). E2 and
DES, a well known artificial estrogen,
induced the highest concentrations of
vitellogenin. The persistent pesticide o,p'-
DDT induced smaller amounts of vitel-
logenin in a dose-dependent manner. No
vitellogenin was extractable from the con-
trol plasma or detectable using 1D-SDS-
PAGE and Western blot analyses, indicat-
ing that the slight absorbance of control
plasma in ELISA analyses is attributed to
nonspecific binding of the polyclonal
antibody (Figure 2).
*...........
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Figure 1. Western blot of plasma from a 1D-SDS-
PAGE of control (lane A) and estrogen-treated (lane B)
male turtles (Trachemys scripta) using antivitellogenin
antibody. A protein of 214 kDa (arrow), vitellogenin, is
present in plasma of estrogen-treated specimens, but
not in controls.
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Figure 2. Vitellogenin induction in male turtles treated
for 7 days with 1 pg/g estradiol-17), 1 pg/g DES, 250
pg/g o,p'DDT, or 1 pg/g o,p'-DDT. Plasma was collect-
ed on day 14 of treatment. Vitellogenin was measured
using ELISA with purified polyclonal antibody to turtle
(T. scripta) vitellogenin. Treatments are significantly
different at p<0.001. Treatment groups with different
letter designations are statistically different by the
Student-Newman-Keuls method.
Inducton ofVltellogenin inFrogs
A protein of approximately 200 kDa was
extractable from the plasma offrogs treated
with E2, DES, and both DDT regimes
(Figure 3), but was not extractable from
the plasma ofcontrol specimens. This pro-
tein was purified as described above and
identified as vitellogenin. However, this
protein demonstrated no cross-reactivity
with the antiturtle vitellogenin antibodies.
Computerized image analysis of ID-SDS-
PAGE was used to quantify relative con-
centrations ofvitellogenin induced by the
treatment regimes. The pattern of vitel-
logenin production in frogs mirrored that
seen in turtles, with significant variation
(p< 0.001) in relative quantities of vitel-
logenin produced by treatments (Figure 4).
E2 induced the most vitellogenin, followed
by DES and o,p'-DDT in a dose-depen-
dent fashion. No extractable vitellogenin
was detectable by ID-SDS-PAGE from
control samples.
Discussion
DES was developed as a synthetic estrogen
that was used to prevent premature births
in women beginning in 1948. Over 1 mil-
lion women took DES between 1960 and
1970 (1). DES was shown to have signifi-
cant detrimental effects on embryonic
development in humans and animal
models, and was subsequently banned
from use by pregnant women in 1971.
Daughters ofwomen who took DES suffer
reproductive organ dysfunction, reduced
fertility, abnormal pregnancies (39), and
increased incidence of vaginal clear-cell
adenocarcinomas (40). Similar reproduc-
tive and developmental problems have
been seen in female laboratory animals
(39,41-43). Exposure ofmale humans and
A B
Figure 3. Coomassie blue-stained 5% 1D-SDS-poly-
acrylamide gel of vitellogenin extracted from plasma
from control (lane A) and DDT-treated (lane B) male
frogs (Xenopus laevis). Induction of 200 kDa protein,
vitellogenin (arrow), in males is present in plasma of
estrogen-treated specimens, but not in controls.
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Figure 4. Vitellogenin induction in male frogs (Xenopus
laevis) treated for 7 days with 1 pg/g estradiol-173, 1
pg/g DES, 250 pg/g o,p'-DDT, or 1 pg/g o,p'-DDT.
Plasma was collected on day 14 of treatment.
Vitellogenin concentration was quantified from 1D-SDS-
PAGE by computerized image analysis. Treatments are
significantly different at p<0.001. Treatment groups
with different letter designations are statistically differ-
ent by Student-Newman-Keuls method.
male laboratory animals to DES during
development leads to lesions of the repro-
ductive system (44,45) and an increased
incidence of reproductive tract cancers in
laboratory animals (46). The mechanism
of DES action has been well studied. It is
an agonist ofestrogen receptors, binding to
them and eliciting transcription of estro-
gen-induced proteins (39,47).
The use ofthe organochlorine pesticide
DDT was restricted in the United States in
1972; however, elevated levels ofDDT and
its metabolites are still encountered in the
tissues of wildlife in this country (48).
Although some of this can be due to
DDT's long half-life (57.7 years) in tem-
perate soils (49), this does not entirely
account for the continuing high levels. A
likely source is the continued manufacture
and use of DDT in developing countries
(1). DDT used in developing countries is
readily vaporized and transported globally
via the atmosphere (50,51), providing a
continuing rain of DDT throughout the
world. This indicates that DDT is still an
important environmental hazard and serves
as a good model for physiological studies
due to the extensive studies on its mecha-
nism ofaction.
DDT is well known for its effects on
reproduction in avian species, most notably
causing eggshell thinning (52). However,
the role of DDT as an estrogen has been
more insidious (53). DDT has two
isomers, p,p'-DDT and o,p'-DDT, which
break down into their respective metabo-
lites, p,p'-DDE and o,p'-DDE (53). The
o,p' isomers of DDT and DDE bind to
estrogen receptors agonistically, mimicking
endogenous estrogen (54,55).
The induction of vitellogenin by a
compound indicates that it is an agonist of
hepatic estrogen receptors, stimulating
them to induce transcription of the vitel-
logenin genes. Both the artificial estrogen,
DES and the pesticide DDT were able to
stimulate male turtles and frogs to produce
significant levels of vitellogenin. DES has
been shown to bind to nuclear estrogen
receptors in turtles, inhibiting 96.7% of
specifically bound E2 (56). In the environ-
ment, DDT is known to accumulate in
large concentrations in turtles and frogs.
The softshell turtle has been recorded with
732 ppm DDT in adults (57). Adult toads
have exhibited 0.13 ppm DDT (57).
An insidious aspect of lipophilic
compounds is that they are also deposited
in eggs during vitellogenesis. It is likely
that as lipids are mobilized from body
stores, lipophilic contaminants also are
mobilized and become incorporated into
the growing ovarian follicles. Thus the
adult's burden of lipophilic contaminants
may be passed on to their offspring, where
they can influence the fertilizability of the
egg and development of the embryo, the
most sensitive period ofthe life cycle. Eggs
ofloggerhead sea turtles exhibited approxi-
mately 0.1 ppm DDE (58), equal to the
highest levels detected in the adult turtles
(59). In the snapping turtle, up to 864
ppb DDT has been reported in their eggs
(60). The levels of organochlorine conta-
minants in reptilian eggs correlates with
increases in deformities and lowered rates
of hatching success (61). In species that
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exhibit temperature-dependent sex deter-
mination (TSD), such as many turtles, the
implications for effects by environmental
estrogens are enormous. The sex of the
offspring in species that exhibit TSD is
regulated by levels ofsex steroids (62,63).
By increasing levels of perceived estrogen,
xenobiotic estrogens may adversely affect
sexual development in these species. It has
been shown that exposure ofturtle eggs to
xenobiotic estrogens induces ovary-like
characteristics in hatchlings incubated at
male-producing temperatures (64).
Vitellogenin may prove useful as a
biomarker for exposure to xenobiotic
estrogens due to its numerous advantages.
First, it is applicable to a wide range of
species, potentially any oviparous or ovovi-
viparous vertebrate. The criterion for
using vitellogenin as a biomarker in a
particular species is that males do not nor-
mally express vitellogenin, but are capable
ofdoing so in response to estrogenic com-
pounds. Second, the test is relatively non-
invasive, requiring only small (microliter)
quantities ofplasma or serum. This elimi-
nates the necessity of acquiring tissue
biopsies of organs such as liver, muscle,
and fat. Third, it indicates a physiological
response to an environmental challenge,
indicating that the animal is being influ-
enced by environmental estrogens. This
eliminates the confusion often encoun-
tered when contaminants are detected in
wildlife, but without knowing ifthe conta-
minant is causing any physiological effects.
Fourth, the expression of vitellogenin is
through known physiological and bio-
chemical pathways. Indeed, the induction
ofvitellogenin has been studied intensively
as a model for steroid regulation of gene
expression and protein synthesis (4-13).
Fifth, the induction ofvitellogenin is sen-
sitive to any estrogenic contaminant. In
fact, the vitellogenic response has been
used to screen unknown compounds for
estrogenic properties (29,30). Sixth, the
response is quantifiable. Finally, the assay
for vitellogenin can be performed relative-
ly easily and inexpensively, especially com-
pared to the exorbitant cost of screening
for a wide range of specific contaminants.
The vitellogenic response has been used to
test for exposure to estrogenic xenobiotics
in fishes (26-30).
There are, however, several drawbacks
regarding vitellogenin analysis that must
be considered. It is unlikely that the pro-
duction ofvitellogenin in males represents
a seriously deleterious physiological
response. This assay also provides no
direct information regarding the female or
developing embryo. However, if estrogen
receptors are being stimulated in the liver
ofmales, receptors in other organs such as
the testes and prostate gland ofmales and
reproductive tissues of females and
embryos may likewise be affected. In fact,
since females and embryos often show
greater responses to estrogen, they may be
affected equally or even more so. Further,
vitellogenin production does not indicate
what compound may be causing the effect.
However, it may be used as a rapid, sensi-
tive, and economical initial screen,
followed (as indicated by positive vitel-
logenic responses) by more costly screens
to identify the specific contaminating
compounds. This assay assumes that males
do not produce vitellogenin but are capa-
ble of doing so. This requires that some
physiology of the species be known, such
as comparing contaminated populations to
clean control populations. These limita-
tions considered, vitellogenin may serve as
an excellent biomarker for xenobiotic
estrogen exposure in reptiles and amphib-
ians or other oviparous and ovoviviparous
vertebrates.
Increasingly more evidence ofthe estro-
genic effects ofcontaminants on wildlife is
appearing. In the late 1970s, male herring
gull embryos and chicks from Lake
Ontario showed the development of
oviducts and ovarylike gonads. Laboratory
studies have since shown that estrogenic
pesticides such as dicofol, kelthane, and
methoxychlor produce these effects in
California gulls, western gulls, and kestrels
(65). Herring gull populations contami-
nated with estrogenic compounds such as
DDT, DDE, and PCBs have been shown
to form female-female pairs (66). In
Florida, the occurrence of demasculinized
and feminized male alligators is associated
with the presence of the estrogenic pesti-
cides (67). Hermaphroditic fish popula-
tions have been reported in the lagoons of
sewage treatment works (27).
Are these examples of wildlife effects
isolated incidents or just the tip of the
iceberg? It is unclear at this point. Some
populations, such as bald eagles surround-
ing the Great Lakes, are still in trouble.
Adult bald eagles that migrate to the lake
shore develop reproductive difficulties asso-
ciated with contaminated food (48). The
Great Lakes is acting as a sink for bald
eagles migrating from reproductively fit
inland populations. Alligators in Lake
Apopka, Florida, have drastically reduced
reproductive success (67,68). These local
populations of long-lived species may be
heading for extinction, because reproduc-
tion on the site is insufficient to maintain
the population size, requiring migration
from surrounding populations to sustain
them. It is possible that the decline of
other species around the globe, such as
amphibians (69-74), is partially linked to
reproductive impairment by endocrine-
disrupting compounds (BD Palmer,
unpublished data). The assay of vitel-
logenin in males ofthese and other species
in the wild would indicate whether they
are being physiologically influenced by the
estrogenic properties of environmental
contaminants.
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